NALTREXONE
| Brand name | VIVITROL |
|---|---|
| Active ingredient | NALTREXONE |
| Strength | 380MG/VIAL |
| Dosage form | FOR SUSPENSION, EXTENDED RELEASE |
| Route | INTRAMUSCULAR |
| Modality | Small molecule |
| FDA approval | April 2006 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 7919499 | October 2029 | use U-1123 |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.